0001209191-18-026617.txt : 20180427 0001209191-18-026617.hdr.sgml : 20180427 20180427164200 ACCESSION NUMBER: 0001209191-18-026617 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170614 FILED AS OF DATE: 20180427 DATE AS OF CHANGE: 20180427 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Trainor-Degirolamo Sheldon CENTRAL INDEX KEY: 0001708966 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38112 FILM NUMBER: 18784692 MAIL ADDRESS: STREET 1: C/O ATHENEX, INC. 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Athenex, Inc. CENTRAL INDEX KEY: 0001300699 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 431985966 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 BUSINESS PHONE: 716-898-8625 MAIL ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20131223 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC DATE OF NAME CHANGE: 20040817 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2017-06-14 2017-06-21 0 0001300699 Athenex, Inc. ATNX 0001708966 Trainor-Degirolamo Sheldon C/O ATHENEX, INC. 1001 MAIN STREET, SUITE 600 BUFFALO NY 14203 1 0 0 0 Stock Option (Right to Buy) 11.00 2017-06-14 4 A 0 19500 0.00 A 2027-06-14 Common Stock 19500 19500 D The option vests in four equal annual installments beginning on June 14, 2018. This amendment is being filed to correct a typographical error in the acquisition date of the option referenced above and related information including the option's exercise and expiration dates and the date of earliest transaction in the Form 4. /s/ Teresa Bair, Attorney-in-Fact 2018-04-27